Search Within

Craig Steven Sauter

  1. "Immunology Program Faculty"
Formats
  1. Meeting Abstract (53)
  2. Journal Article (22)
Groups
  1. Bone Marrow Transplant (75)
  2. Center for Hematologic Malignancies (75)
  3. Department of Medicine (75)
  4. GSK Faculty (75)
  5. Hematologic Malignancies, Division of (75)
  6. Immunology Program Faculty (75)

More Groups

People
  1. Esperanza Papadopoulos (60)
  2. Sergio Giralt (60)
  3. Miguel-Angel Perales (59)
  4. Richard O'Reilly (57)
  5. Juliet Barker (55)
  6. Doris Ponce (52)

More People

Years
  1. 2022 (2)
  2. 2021 (4)
  3. 2020 (9)
  4. 2019 (6)
  5. 2018 (8)
  6. 2017 (8)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (31)
  2. Blood (25)
  3. Bone Marrow Transplantation (5)
  4. Blood Advances (2)
  5. Cancer Research (2)
  6. Journal of Clinical Investigation (2)

More Publications

Publishers
  1. Elsevier Inc. (32)
  2. American Society of Hematology (27)
  3. Nature Publishing Group (6)
  4. American Association for Cancer Research (2)
  5. American Society for Clinical Investigation (2)
  6. American Society of Clinical Oncology (2)

More Publishers

Results (75)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive T-cell therapy with 3rd party CMV-pp65-specific CTLs for CMV viremia and disease arising after allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Rodriguez-Sanchez, I.; Hasan, A. N.; Barker, J.; Castro-Malaspina, H. R.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Kernan, N. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel cy/flu/thio/TBI 400 intermediate intensity conditioning regimen
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Jacob, A.; Maloy, M.; Mazis, C.; Naputo, K.; Scaradavou, A.; O'Reilly, R.; Avecilla, S.; Castro-Malaspina, H. R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Five years of therapy with donor and 3rd party derived EBV and CMV specific cytotoxic T cells - Safety after more than 1,000 infusions
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; Koehne, G.; Dahi, P.; Papadopoulos, E.; Sauter, C.; Rodriguez-Sanchez, I.; Suser, S.; Escobedo, V.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • T cell depletion as an alternative approach for patients 55 years or older undergoing allogeneic stem cell transplantation as curative therapy for hematologic malignancies
    Journal Article

    Jakubowski, A. A.; Petrlik, E.; Maloy, M.; Hilden, P.; Papadopoulos, E.; Young, J. W.; Boulad, F.; Castro-Malaspina, H.; Tamari, R.; Dahi, P. B.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Ex vivo CD34(+)–selected T cell–depleted peripheral blood stem cell grafts for allogeneic hematopoietic stem cell transplantation in acute leukemia and myelodysplastic syndrome is associated with low incidence of acute and chronic graft-versus-host disease and high treatment response
    Journal Article

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Dierov, D.; Nieves, J.; Garrett, M. D.; Sogani, J.; Cho, C.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation comorbidity index predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34(+) selected grafts for allogeneic hematopoietic cell transplantation
    Journal Article

    Barba, P.; Ratan, R.; Cho, C.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Banked EBV-specific T-cells for treatment of rituximab refractory EBV plus B-cell lymphoma in solid organ transplantation recipients
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Sauter, C.; Suser, S.; O'Reilly, R.
    American Journal of Transplantation (2016)

    Fulltext@MSK | Save
  • Chimeric antigen receptor T cells for cancer immunotherapy
    Meeting Abstract

    Curran, K. J.; Silverman, L. B.; Kobos, R.; Kernan, N. A.; Margossian, S. P.; Park, J. H.; Sauter, C. S.; Szenes, V.; Wang, X. Y.; O'Reilly, R. J.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted grafts for allogeneic hematopoietic cell transplantation is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; Papadopoulos, E.; Sauter, C.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save